My account

Shop

Home » Shop » Pen COMBO 4in1 test | COVID-19 | Influenza A+B | RSV | 20 pieces

Pen COMBO 4in1 test | COVID-19 | Influenza A+B | RSV | 20 pieces - Image 2

Pen COMBO 4in1 test | COVID-19 | Influenza A+B | RSV | 20 pieces - Image 3

Pen COMBO 4in1 test | COVID-19 | Influenza A+B | RSV | 20 pieces

219,8 PLN per package (20 pieces)

Work efficiently, order profitably!
Place wholesale orders at info@bisaf.pl

In stock

Product description

Test Pen COMBO 4-in-1 (nasal swab)

This is an innovative and rapid pen-shaped test that allows for the detection of four of the most common respiratory pathogens using a single tool and a single test, without the test casette. Everything needed to perform the test is contained within this one diagnostic device, enabling sample collection, analysis, and result reading in one simple process.

The test is designed for the qualitative and differential detection of antigens of SARS-CoV-2, influenza A and B viruses, and the RSV virus. The sample is collected via a nasal swab. The test is available in a bulk package of 20 pieces.

1 swab = 4 results

The high accuracy of this test ensures reliable results in just 15 minutes!

Product intended for professional use.

This is a medical device. Use it in accordance with the instructions for use or the label.

Properties

sample material: nasal swab
innovative form of the test – Pen
painless sample collection
high product quality
quick results in just 15 minutes!
bulk packaging of 20 pieces
product intended for professional use

Test specification

SARS-CoV-2: specificity: 99,3%, sensitivity: 97%, accuracy: 98,9%
Influenza A: specificity: 98,8%, sensitivity: 94,3%, accuracy: 98,2%
influenza B: specificity: 99%, sensitivity: 93,9%, accuracy: 98,7%
RSV: specificity: 98,8%, sensitivity: 91,4%, accuracy: 98,4%

The package contains

20 individually packaged tests (Pens)
instruction manual

Test application

The Test Pen COMBO 4-in-1 is a modern diagnostic tool designed for the qualitative and differential detection of antigens of the four most common respiratory pathogens: SARS-CoV-2, influenza A and B viruses, and the RSV virus.
It is particularly recommended for medical facilities, including clinics, hospitals, and specialist offices, where rapid viral infection diagnostics are crucial for further therapeutic management.
The test is also suitable for screening in primary care settings and by general practitioners, enabling quick confirmation or exclusion of infection with one of the four most common respiratory pathogens.